Status:
WITHDRAWN
Delaying the Onset of Nearsightedness Until Treatment Study
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
University of Houston
State University of New York
Conditions:
Myopia
Eligibility:
All Genders
6-11 years
Phase:
PHASE1
Brief Summary
Participants eligible for the study will be randomized to one of three concentrations of atropine and followed for a month.
Detailed Description
Participants will be identified through screening that fit the criteria of a pre-myopic child, which will depend on age and the amount of refractive error at that time. These children will be randomiz...
Eligibility Criteria
Inclusion
- Age: 6-11 years
- Refractive error measured in spherical equivalent, one eye meets criterion
- 6 years old: 0.50 to +0.38
- 7 years old: 0.50 to +0.25
- 8-11 years old: 0.50 to plano
- Anisometropia: spherical equivalent \<1.50 D
- Astigmatism: \<1.50 in both eyes
- Myopia: Less myopic than -0.74 D, both eyes
Exclusion
- ● Myopic
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06029530
Start Date
January 1 2024
End Date
August 31 2024
Last Update
April 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.